Asia Pacific Intravenous hydration therapy Market Size study, by Service, by Component, by End User and Country Forecasts 2022-2032

Description

List of Tables

Asia Pacific Intravenous (IV) hydration therapy Market is valued at approximately USD 502.04 million in 2023 and is anticipated to grow with a healthy growth rate of more than 9.64% over the forecast period 2024-2032. The Asia Pacific market for IV Hydration Therapy includes giving fluids directly into the bloodstream to address dehydration and provide crucial nutrients. Numerous notable patterns have driven substantial market expansion. The growing occurrence of long-term illnesses like diabetes and cancer has raised the need for IV hydration treatment, particularly in medical environments. The rise in demand for wellness and preventative healthcare has caused a surge in outpatient clinics and mobile IV therapy services, resulting in market growth. Moreover, the growing number of older people worldwide has increased the need for IV hydration treatment in elderly patients who struggle to drink fluids by mouth. Improvements in technology like smart pumps and integrated monitoring systems are increasing the safety and effectiveness of IV therapy, resulting in further market expansion. These patterns are leading to increased focus and financial backing in the Asia Pacific market for Intravenous (IV) Hydration Therapy.

Diverse factors driving the Asia Pacific Intravenous (IV) Hydration Therapy Market is the rising occurrence of chronic illnesses, which is resulting in a greater need for IV therapy in medical environments. This trend shows an increasing demand for effective and focused hydration options, particularly in patients with complicated medical issues. However, the market also encounters particular limitations. A major limitation is the possible dangers linked to IV treatment, such as infection, excessive fluid, and vein irritation. These dangers require strict procedures and knowledgeable medical staff to guarantee the treatment is both safe and successful. Healthcare providers and industry stakeholders face a critical challenge in weighing the advantages of IV hydration therapy against its risks, which impact market dynamics and adoption rates.

The key Countries considered for the Asia Pacific Intravenous (IV) hydration therapy market study includes China, India, Japan, South Korea, Australia and Rest of Asia Pacific. China stands out as a dominating region due to increasing healthcare investments, rising awareness about hydration therapies, and expanding access to healthcare services. The region's robust reimbursement policies and strong presence of key market players further contribute to its leadership position in the IV Hydration Therapy Market. The region's growing prevalence of chronic diseases and the ageing population are driving demand for IV hydration therapy solutions in the region. Significant players in the field are also continuously focusing on introducing contemporary technologies into the market to meet changing customer demands, which is anticipated to stimulate market growth. The market in India, on the other hand, is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:

Terumo Corporation
Nipro Corporation
Nihon Kohden Corporation
Sinopharm Group Co., Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
China Resources Double-Crane Pharmaceutical Co., Ltd.
Sun Pharmaceutical Industries Ltd.
Lupin Limited
Cadila Healthcare Limited
Daewoong Pharmaceutical Co., Ltd.

The detailed segments and sub-segment of the market are explained below:

By Service

Immune Boosters
Energy Boosters
Skin Care
Migraine
Other

By Component

Medicated
Non-medicated

By End User

Hospitals & Clinics
Wellness centres and spas
Home Healthcare
Others

By Region:

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1.Asia Pacific Intravenous (IV) Hydration Therapy Market Definition and Research Assumptions

1.1.Research Objective
1.2.Market Definition
1.3.Research Assumptions
- 1.3.1.Inclusion & Exclusion
- 1.3.2.Limitations
- 1.3.3.Supply Side Analysis
  - 1.3.3.1.Availability
  - 1.3.3.2.Infrastructure
  - 1.3.3.3.Regulatory Environment
  - 1.3.3.4.Market Competition
  - 1.3.3.5.Economic Viability (Consumer's Perspective)
- 1.3.4.Demand Side Analysis
  - 1.3.4.1.Regulatory frameworks
  - 1.3.4.2.Technological Advancements
  - 1.3.4.3.Environmental Considerations
  - 1.3.4.4.Consumer Awareness & Acceptance
1.4.Estimation Methodology
1.5.Years Considered for the Study
1.6.Currency Conversion Rates

Chapter 2.Executive Summary

2.1.Asia Pacific Intravenous (IV) Hydration Therapy Market Size & Forecast (2022- 2032)
2.2.Regional Summary
2.3.Segmental Summary
- 2.3.1.By Service
- 2.3.2.By Component
- 2.3.3.By End User
2.4.Key Trends
2.5.Recession Impact
2.6.Analyst Recommendation & Conclusion

Chapter 3.Asia Pacific Intravenous (IV) Hydration Therapy Market Dynamics

3.1.Market Drivers
3.2.Market Challenges
3.3.Market Opportunities

Chapter 4.Asia Pacific Intravenous (IV) Hydration Therapy Market Industry Analysis

4.1.Porter's 5 Force Model
- 4.1.1.Bargaining Power of Suppliers
- 4.1.2.Bargaining Power of Buyers
- 4.1.3.Threat of New Entrants
- 4.1.4.Threat of Substitutes
- 4.1.5.Competitive Rivalry
- 4.1.6.Futuristic Approach to Porter's 5 Force Model
- 4.1.7.Porter's 5 Force Impact Analysis
4.2.PESTEL Analysis
- 4.2.1.Political
- 4.2.2.Economical
- 4.2.3.Social
- 4.2.4.Technological
- 4.2.5.Environmental
- 4.2.6.Legal
4.3.Top investment opportunity
4.4.Top winning strategies
4.5.Disruptive Trends
4.6.Industry Expert Perspective
4.7.Analyst Recommendation & Conclusion

Chapter 5.Asia Pacific Intravenous (IV) Hydration Therapy Market Size & Forecasts by Service 2022-2032

5.1.Immune Boosters
5.2.Energy Boosters
5.3.Skin Care
5.4.Migraine
5.5.Other

Chapter 6.Asia Pacific Intravenous (IV) Hydration Therapy Market Size & Forecasts by Component 2022-2032

6.1. Medicated
6.2.Non-medicated

Chapter 7.Asia Pacific Intravenous (IV) Hydration Therapy Market Size & Forecasts by End User 2022-2032

7.1.Hospitals & Clinics
7.2.Wellness centres and spas
7.3.Home Healthcare
7.4.Others

Chapter 8.Asia Pacific Intravenous (IV) Hydration Therapy Market Size & Forecasts by Country 2022-2032

8.1.China Intravenous (IV) Hydration Therapy Market
- 8.1.1.Service breakdown size & forecasts, 2022-2032
- 8.1.2.Component breakdown size & forecasts, 2022-2032
- 8.1.3.End User breakdown size & forecasts, 2022-2032
8.2.India Intravenous (IV) Hydration Therapy Market
8.3.Japan Intravenous (IV) Hydration Therapy Market
8.4.Australia Intravenous (IV) Hydration Therapy Market
8.5.South Korea Intravenous (IV) Hydration Therapy Market
8.6.Rest of Asia Pacific Intravenous (IV) Hydration Therapy Market

Chapter 9.Competitive Intelligence

9.1.Key Company SWOT Analysis
9.2.Top Market Strategies
9.3.Company Profiles
- 9.3.1. Terumo Corporation
  - 9.3.1.1.Key Information
  - 9.3.1.2.Overview
  - 9.3.1.3.Financial (Subject to Data Availability)
  - 9.3.1.4.Product Summary
  - 9.3.1.5.Market Strategies
- 9.3.2. Nipro Corporation
- 9.3.3.Nihon Kohden Corporation
- 9.3.4.Sinopharm Group Co., Ltd.
- 9.3.5.Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- 9.3.6.China Resources Double-Crane Pharmaceutical Co., Ltd.
- 9.3.7.Sun Pharmaceutical Industries Ltd.
- 9.3.8.Lupin Limited
- 9.3.9.Cadila Healthcare Limited
- 9.3.10.Daewoong Pharmaceutical Co., Ltd.

Chapter 10.Research Process

10.1.Research Process
- 10.1.1.Data Mining
- 10.1.2.Analysis
- 10.1.3.Market Estimation
- 10.1.4.Validation
- 10.1.5.Publishing
10.2.Research Attributes

LIST OF TABLES

TABLE 1.Asia Pacific Intravenous (IV) Hydration Therapy market, report scope
TABLE 2.Asia Pacific Intravenous (IV) Hydration Therapy market estimates & forecasts by Country 2022-2032 (USD Million)
TABLE 3.Asia Pacific Intravenous (IV) Hydration Therapy market estimates & forecasts by Service 2022-2032 (USD Million)
TABLE 4.Asia Pacific Intravenous (IV) Hydration Therapy market estimates & forecasts by Component 2022-2032 (USD Million)
TABLE 5. Asia Pacific Intravenous (IV) Hydration Therapy market estimates & forecasts by End User 2022-2032 (USD Million)
TABLE 6.Asia Pacific Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7.Asia Pacific Intravenous (IV) Hydration Therapy market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8.Asia Pacific Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9.Asia Pacific Intravenous (IV) Hydration Therapy market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10.Asia Pacific Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11.Asia Pacific Intravenous (IV) Hydration Therapy market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12.Asia Pacific Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13.Asia Pacific Intravenous (IV) Hydration Therapy market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14.Asia Pacific Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 15.Asia Pacific Intravenous (IV) Hydration Therapy market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 16.China Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Million)
TABLE 17.China Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 18.China Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 19.India Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Million)
TABLE 20.India Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 21.India Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 22.Japan Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Million)
TABLE 23.Japan Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 24.Japan Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 25.Australia Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Million)
TABLE 26.Australia Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 27.Australia Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 28.South Korea Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Million)
TABLE 29.South Korea Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 30.South Korea Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 31.
TABLE 32.RoAPAC Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Million)
TABLE 33.RoAPAC Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 34.RoAPAC Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 35.List of secondary sources, used in the study of Asia Pacific Intravenous (IV) Hydration Therapy Market.
TABLE 36.List of primary sources, used in the study of Asia Pacific Intravenous (IV) Hydration Therapy Market.
TABLE 37.Years considered for the study.
TABLE 38.Exchange rates considered.

LIST OF FIGURES

FIG 1.Asia Pacific Intravenous (IV) Hydration Therapy market, research methodology
FIG 2.Asia Pacific Intravenous (IV) Hydration Therapy market, market estimation techniques
FIG 3.Asia Pacific market size estimates & forecast methods.
FIG 4.Asia Pacific Intravenous (IV) Hydration Therapy market, key trends 2023
FIG 5.Asia Pacific Intravenous (IV) Hydration Therapy market, growth prospects 2022-2032
FIG 6.Asia Pacific Intravenous (IV) Hydration Therapy market, porters 5 force model
FIG 7.Asia Pacific Intravenous (IV) Hydration Therapy market, pestel analysis
FIG 8.Asia Pacific Intravenous (IV) Hydration Therapy market, value chain analysis
FIG 9.Asia Pacific Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 10.Asia Pacific Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 11.Asia Pacific Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 12.Asia Pacific Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 13.Asia Pacific Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 14.Asia Pacific Intravenous (IV) Hydration Therapy market, Country snapshot 2022 & 2032
FIG 15.Asia pacific Intravenous (IV) Hydration Therapy market 2022 & 2032 (USD Million)
FIG 16.Asia Pacific Intravenous (IV) Hydration Therapy market, company market share analysis (2023)